drug

RO7204239

1 story · latest Nov 6, 2026

Follow RO7204239. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Code: GYM329
Trials: 4 registered trials in coverage

Relationships

Developed by Roche

Timeline

Roche registers giredestrant Phase 3 trial; six other studies update

Nov 6Weekly roundup, 16 itemsAbbVie alectinibUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.